BR112012021532A2 - composição para tratamento de unhas com fungo - Google Patents

composição para tratamento de unhas com fungo

Info

Publication number
BR112012021532A2
BR112012021532A2 BR112012021532A BR112012021532A BR112012021532A2 BR 112012021532 A2 BR112012021532 A2 BR 112012021532A2 BR 112012021532 A BR112012021532 A BR 112012021532A BR 112012021532 A BR112012021532 A BR 112012021532A BR 112012021532 A2 BR112012021532 A2 BR 112012021532A2
Authority
BR
Brazil
Prior art keywords
nail
fungus
composition
treatment
present
Prior art date
Application number
BR112012021532A
Other languages
English (en)
Other versions
BR112012021532B1 (pt
Inventor
Johnson Neil
Original Assignee
Lrc Products
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lrc Products filed Critical Lrc Products
Publication of BR112012021532A2 publication Critical patent/BR112012021532A2/pt
Publication of BR112012021532B1 publication Critical patent/BR112012021532B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D29/00—Manicuring or pedicuring implements
    • A45D29/04—Nail files, e.g. manually operated
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D29/00—Manicuring or pedicuring implements
    • A45D29/18—Manicure or pedicure sets, e.g. combinations without case, etui, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

composição para tratamento de unhas com fungo. a presente invenção provê uma composição para tratamento de unhas com fungo compreendendo uma fonte de próton, um umectante, um agente de formação de filme, um agente para intensificar penetração, pelo menos um solvente, e opcionalmente pelo menos um componente adicional selecionado do grupo que consiste em um ou mais condicionadores de unhas, consevantes, inibidores de uv, pigmentos, corantes e perfumes. em outros aspectos, a presente invenção provê um processo para a preparação de uma composição para tratamento de unhas com fungo, uso da composição no tratamento de infecção de unhas com fungo, um dispositivo para tratamento de unhas com fungo, e um kit compreendendo uma composição para tratamento de unhas com fungo da presente invenção em combinação com um dispositivo para tratamento de unhas com fungo da presente invenção.
BR112012021532-9A 2010-02-26 2011-02-25 Composição para tratamento de unhas com fungo BR112012021532B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1003336.3 2010-02-26
GB1003336A GB2478159A (en) 2010-02-26 2010-02-26 Composition for the treatment of fungal nail infection
PCT/GB2011/050379 WO2011104562A1 (en) 2010-02-26 2011-02-25 Fungal nail treatment composition

Publications (2)

Publication Number Publication Date
BR112012021532A2 true BR112012021532A2 (pt) 2017-11-14
BR112012021532B1 BR112012021532B1 (pt) 2019-07-02

Family

ID=42125744

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012021532-9A BR112012021532B1 (pt) 2010-02-26 2011-02-25 Composição para tratamento de unhas com fungo

Country Status (10)

Country Link
EP (1) EP2538938B1 (pt)
JP (1) JP2013520483A (pt)
CN (1) CN102844026A (pt)
AU (1) AU2011219546B2 (pt)
BR (1) BR112012021532B1 (pt)
ES (1) ES2732892T3 (pt)
GB (1) GB2478159A (pt)
PL (1) PL2538938T3 (pt)
TW (1) TW201138860A (pt)
WO (1) WO2011104562A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3047664B1 (fr) * 2016-02-15 2019-08-02 Jean Robert Pascoualle Principe actif apportant une solution therapeutique a des pathologies de l'ongle (onychomycoses,....et affilies), du lit ungueal, et des zones peripheriques
BE1025004B1 (nl) * 2017-02-24 2018-09-24 Oystershell Nv Afpelbare nagellak
EP3713583A4 (en) * 2017-11-21 2021-06-30 Topix Pharmaceuticals, Inc. METHODS AND COMPOSITIONS FOR TREATMENT OF THE SKIN
KR20210107043A (ko) * 2018-12-19 2021-08-31 말린즈 파마 엘엘씨 국소 조성물
CN113208937A (zh) * 2020-01-21 2021-08-06 中国医学科学院北京协和医院 一种角质软化组合物及其制备方法和应用及治疗灰指甲的外用复方及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1003340A (en) 1963-07-30 1965-09-02 Automotive Prod Co Ltd Improvements in and relating to diaphragm spring clutches
CN1040839C (zh) * 1993-03-06 1998-11-25 青岛海洋大学 指甲露
US20030235607A1 (en) * 1998-02-13 2003-12-25 Buck Carol J. Compositions and methods for inhibiting fungal growth and transference
NZ506925A (en) * 1998-04-17 2003-03-28 Bertek Pharm Inc Topical formulations for the treatment of nail fungal diseases
AU3157101A (en) * 2000-01-03 2001-07-16 Manfred Bohn Preparations for the non-traumatic excision of a nail
GB2358627A (en) * 2000-01-28 2001-08-01 Bon Bon Buddies Ltd Dispenser for confectionery products
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US6921529B2 (en) * 2002-07-29 2005-07-26 Joseph C. Maley Treatment modality and method for fungal nail infection
US8486426B2 (en) * 2002-07-29 2013-07-16 Kimberly-Clark Worldwide, Inc. Methods and compositions for treatment of dermal conditions
FR2844197B1 (fr) * 2002-09-05 2006-06-23 Galderma Res & Dev Solution pour application ungueale et peri-ungeale
MXPA05002065A (es) 2002-09-05 2005-06-08 Galderma Sa Solucion para aplicacion ungueal.
US20050018199A1 (en) * 2003-07-24 2005-01-27 Leblanc Philip R. Fiber array interferometer for inspecting glass sheets
AT414096B (de) * 2005-05-03 2006-09-15 Franz Kemptner Antimykotikum
AU2007260739A1 (en) * 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
EP2124878B1 (en) * 2007-02-05 2015-09-02 Biophile Corporation, Ltd Increased effectiveness of allylamine drug compounds
CN101099857A (zh) * 2007-02-13 2008-01-09 贵州神奇集团控股有限公司 治疗脚手癣、灰指甲的中西复方制剂及其制备方法和质控方法
FR2931683B1 (fr) * 2008-06-02 2011-10-28 Galderma Res & Dev Dispositif d'application d'un produit de traitement sur une surface a traiter, utilisation d'un tel dispositif pour le traitement d'un ongle de pied ou de la main et kit de traitement correspondant.
AU2010283031A1 (en) * 2009-08-13 2012-01-19 Moberg Derma Ab Compositions and methods for treating fungal infection of the nail

Also Published As

Publication number Publication date
GB2478159A (en) 2011-08-31
WO2011104562A1 (en) 2011-09-01
EP2538938B1 (en) 2019-04-24
RU2012141024A (ru) 2014-04-10
ES2732892T3 (es) 2019-11-26
TW201138860A (en) 2011-11-16
AU2011219546A1 (en) 2012-09-13
GB201003336D0 (en) 2010-04-14
JP2013520483A (ja) 2013-06-06
BR112012021532B1 (pt) 2019-07-02
EP2538938A1 (en) 2013-01-02
AU2011219546B2 (en) 2016-01-14
CN102844026A (zh) 2012-12-26
PL2538938T3 (pl) 2019-09-30

Similar Documents

Publication Publication Date Title
BRPI0517009A (pt) madeira
CO7240372A2 (es) Formulaciones farmacéuticas tópicas no acuosas
CL2008001124A1 (es) Formulacion farmaceutica que comprende al menos un derivado de acido lipoico y un reactivo formador de par ionico, util en el tratamiento del cancer.
BR112012021532A2 (pt) composição para tratamento de unhas com fungo
EP2437596A4 (en) SKIN TREATMENT COMPOSITIONS
BR112012033091A2 (pt) método de cimentação, e, composição de cimento
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
BR112015010182A8 (pt) processo e kit para alisar e tingir o cabelo e uso dos mesmos
BRPI0905733B8 (pt) composição, formulação farmacêutica, método para a produção de uma composição farmacêutica e uso de uma formulação farmacêutica
BR112015019657A8 (pt) composições tópicas, kit e método para aumentar a liberação de óxido nítrico a partir de um gel tópico anidro contendo uma macromolécula modificada de diazeniodiolato
WO2009131730A3 (en) IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS
BR112013014003A2 (pt) Métodos de redução de produção de sebo na pele
BR112017025221A2 (pt) composições cosméticas compreendendo esclareolida
BR112014012524A2 (pt) composições compreendendo um componente de estabilidade do prazo de validade
BR112012031163A2 (pt) métodos de terapia combinada para tratamento de doenças proliferativas
BR112013000386A2 (pt) combinação de polímero acrílico, composição, e, métodos para mascarar uma combinação polimérica com base em acrílico, e para espessar uma composição aquosa
GT200900201A (es) Formulaciones para el tratamiento del cáncer.
EP2231761A4 (en) QUATERNARY AMMONIUM POLYMERS DISINFECTANTS SOLUBLE IN ALCOHOL
EA201791850A1 (ru) Борсодержащие малые молекулы
CL2008001373A1 (es) Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer.
BR112015021456A2 (pt) uso tópico de uma formulação antimicrobiana
BR112015001414A2 (pt) composição antideriva
CL2009001215A1 (es) Composiciones farmaceuticas que comprenden un primer agente seleccionado del grupo consistente de i) un agente antiinflamatorio, ii) acetaminofeno, iii) fenacetina, iv) tramadol, y un segundo agente; uso de dichas composiciones para tratar enfermedades proliferativas incluyendo cancer.
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
PE20130701A1 (es) Composicion de pigmentos solubles en agua o en solventes organicos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/02/2011, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/02/2011, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2711 DE 20-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.